These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33545341)

  • 21. Metabolomic profiling during the differentiation of human induced pluripotent stem cells into hepatocyte-like cells.
    Jellali R; Lereau Bernier M; Tauran Y; Gilard F; Danoy M; Kido T; Miyajima A; Sakai Y; Leclerc E
    Differentiation; 2020; 112():17-26. PubMed ID: 31869687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptional, Functional, and Mechanistic Comparisons of Stem Cell-Derived Hepatocytes, HepaRG Cells, and Three-Dimensional Human Hepatocyte Spheroids as Predictive In Vitro Systems for Drug-Induced Liver Injury.
    Bell CC; Lauschke VM; Vorrink SU; Palmgren H; Duffin R; Andersson TB; Ingelman-Sundberg M
    Drug Metab Dispos; 2017 Apr; 45(4):419-429. PubMed ID: 28137721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guide to the Assessment of Mature Liver Gene Expression in Stem Cell-Derived Hepatocytes.
    Zabulica M; Srinivasan RC; Vosough M; Hammarstedt C; Wu T; Gramignoli R; Ellis E; Kannisto K; Collin de l'Hortet A; Takeishi K; Soto-Gutierrez A; Strom SC
    Stem Cells Dev; 2019 Jul; 28(14):907-919. PubMed ID: 31122128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Chimeric Humanized Mouse Model by Engrafting the Human Induced Pluripotent Stem Cell-Derived Hepatocyte-Like Cell for the Chronic Hepatitis B Virus Infection.
    Yuan L; Liu X; Zhang L; Li X; Zhang Y; Wu K; Chen Y; Cao J; Hou W; Zhang J; Zhu H; Yuan Q; Tang Q; Cheng T; Xia N
    Front Microbiol; 2018; 9():908. PubMed ID: 29867819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene networks and transcription factor motifs defining the differentiation of stem cells into hepatocyte-like cells.
    Godoy P; Schmidt-Heck W; Natarajan K; Lucendo-Villarin B; Szkolnicka D; Asplund A; Björquist P; Widera A; Stöber R; Campos G; Hammad S; Sachinidis A; Chaudhari U; Damm G; Weiss TS; Nüssler A; Synnergren J; Edlund K; Küppers-Munther B; Hay DC; Hengstler JG
    J Hepatol; 2015 Oct; 63(4):934-42. PubMed ID: 26022688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HiPSC-Derived Hepatocyte-like Cells Can Be Used as a Model for Transcriptomics-Based Study of Chemical Toxicity.
    Ghosh S; De Smedt J; Tricot T; Proença S; Kumar M; Nami F; Vanwelden T; Vidal N; Jennings P; Kramer NI; Verfaillie CM
    Toxics; 2021 Dec; 10(1):. PubMed ID: 35051043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiation and transplantation of human induced pluripotent stem cell-derived hepatocyte-like cells.
    Asgari S; Moslem M; Bagheri-Lankarani K; Pournasr B; Miryounesi M; Baharvand H
    Stem Cell Rev Rep; 2013 Aug; 9(4):493-504. PubMed ID: 22076752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Donor-Dependent and Other Nondefined Factors Have Greater Influence on the Hepatic Phenotype Than the Starting Cell Type in Induced Pluripotent Stem Cell Derived Hepatocyte-Like Cells.
    Heslop JA; Kia R; Pridgeon CS; Sison-Young RL; Liloglou T; Elmasry M; Fenwick SW; Mills JS; Kitteringham NR; Goldring CE; Park BK
    Stem Cells Transl Med; 2017 May; 6(5):1321-1331. PubMed ID: 28456008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amino acid levels determine metabolism and CYP450 function of hepatocytes and hepatoma cell lines.
    Boon R; Kumar M; Tricot T; Elia I; Ordovas L; Jacobs F; One J; De Smedt J; Eelen G; Bird M; Roelandt P; Doglioni G; Vriens K; Rossi M; Vazquez MA; Vanwelden T; Chesnais F; El Taghdouini A; Najimi M; Sokal E; Cassiman D; Snoeys J; Monshouwer M; Hu WS; Lange C; Carmeliet P; Fendt SM; Verfaillie CM
    Nat Commun; 2020 Mar; 11(1):1393. PubMed ID: 32170132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mapping Interindividual Variability of Toxicodynamics Using High-Throughput Transcriptomics and Primary Human Hepatocytes from Fifty Donors.
    Niemeijer M; Więcek W; Fu S; Huppelschoten S; Bouwman P; Baze A; Parmentier C; Richert L; Paules RS; Bois FY; van de Water B
    Environ Health Perspect; 2024 Mar; 132(3):37005. PubMed ID: 38498338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differentiation of hepatocytes from induced pluripotent stem cells derived from human hair follicle mesenchymal stem cells.
    Shi X; Lv S; He X; Liu X; Sun M; Li M; Chi G; Li Y
    Cell Tissue Res; 2016 Oct; 366(1):89-99. PubMed ID: 27053247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptome Profiling Reveals Distinct Phenotype of Human Bone Marrow Mesenchymal Stem Cell-derived Hepatocyte-like cells.
    Shi D; Xin J; Lu Y; Ding W; Jiang J; Zhou Q; Sun S; Guo B; Zhou X; Li J
    Int J Med Sci; 2020; 17(2):263-273. PubMed ID: 32038110
    [No Abstract]   [Full Text] [Related]  

  • 33. [Research advances in hepatocyte-like cells from human induced pluripotent stem cells and their application].
    Cao YY; Zeng X
    Zhonghua Gan Zang Bing Za Zhi; 2018 Jan; 26(1):69-72. PubMed ID: 29804367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exosomes from Human-Induced Pluripotent Stem Cell-Derived Mesenchymal Stromal Cells (hiPSC-MSCs) Protect Liver against Hepatic Ischemia/ Reperfusion Injury via Activating Sphingosine Kinase and Sphingosine-1-Phosphate Signaling Pathway.
    Du Y; Li D; Han C; Wu H; Xu L; Zhang M; Zhang J; Chen X
    Cell Physiol Biochem; 2017; 43(2):611-625. PubMed ID: 28934733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-122: a novel hepatocyte-enriched in vitro marker of drug-induced cellular toxicity.
    Kia R; Kelly L; Sison-Young RL; Zhang F; Pridgeon CS; Heslop JA; Metcalfe P; Kitteringham NR; Baxter M; Harrison S; Hanley NA; Burke ZD; Storm MP; Welham MJ; Tosh D; Küppers-Munther B; Edsbagge J; Starkey Lewis PJ; Bonner F; Harpur E; Sidaway J; Bowes J; Fenwick SW; Malik H; Goldring CE; Park BK
    Toxicol Sci; 2015 Mar; 144(1):173-85. PubMed ID: 25527335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of interindividual differences in hepatic functions and drug sensitivity by using human iPS-derived hepatocytes.
    Takayama K; Morisaki Y; Kuno S; Nagamoto Y; Harada K; Furukawa N; Ohtaka M; Nishimura K; Imagawa K; Sakurai F; Tachibana M; Sumazaki R; Noguchi E; Nakanishi M; Hirata K; Kawabata K; Mizuguchi H
    Proc Natl Acad Sci U S A; 2014 Nov; 111(47):16772-7. PubMed ID: 25385620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatocyte-like cells differentiated from human induced pluripotent stem cells: relevance to cellular therapies.
    Yu Y; Liu H; Ikeda Y; Amiot BP; Rinaldo P; Duncan SA; Nyberg SL
    Stem Cell Res; 2012 Nov; 9(3):196-207. PubMed ID: 22885101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Automated Generation of hiPSC-Derived Hepatic Progeny by Cost-Efficient Compounds.
    Vanmarcke G; Sai-Hong Chui J; Cooreman A; De Vos K; Cleuren L; Van Rossom R; García-Llorens G; Izuel Idoype T; Boon R; Kumar Gautam M; Castell JV; Annaert P; Lluis F; Verfaillie CM
    Stem Cells; 2023 Nov; 41(11):1076-1088. PubMed ID: 37616601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accumulation of Toxic Advanced Glycation End-Products Induces Cytotoxicity and Inflammation in Hepatocyte-Like Cells Differentiated from Human Induced Pluripotent Stem Cells.
    Kikuchi C; Sakasai-Sakai A; Okimura R; Tanaka H; Takata T; Takeuchi M; Matsunaga T
    Biol Pharm Bull; 2021; 44(10):1399-1402. PubMed ID: 34602548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pan-Genotype Hepatitis E Virus Replication in Stem Cell-Derived Hepatocellular Systems.
    Wu X; Dao Thi VL; Liu P; Takacs CN; Xiang K; Andrus L; Gouttenoire J; Moradpour D; Rice CM
    Gastroenterology; 2018 Feb; 154(3):663-674.e7. PubMed ID: 29277559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.